Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial

• Matthew B. Schabath ,

  * E-mail: Matthew.Schabath@Moffitt.org

  Affiliation Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America

  http://orcid.org/0000-0003-3241-3216

  ⨯
• Pierre P. Massion,

  Affiliation Thoracic Program, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States of America

  ⨯
• Zachary J. Thompson,

  Affiliation Department of Biostatistics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America

  ⨯
• Steven A. Eschrich,

  Affiliation Department of Biomedical Informatics, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America

  ⨯
• Yoganand Balagurunathan,

  Affiliation Department of Cancer Imaging, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America

  ⨯
• Dmitry Goldof,

  Affiliation Department of Computer Science and Engineering; University of South Florida, Tampa, Florida, United States of America

  ⨯
• Denise R. Aberle,

  Affiliation Department of Radiological Sciences; David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America

  ⨯
• Robert J. Gillies

  Affiliation Department of Cancer Imaging, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States of America

  ⨯